ORATECT ORAL FLUID DRUG SCREEN DEVICES

Enzyme Immunoassay, Cocaine And Cocaine Metabolites

BRANAN MEDICAL CORPORATION

The following data is part of a premarket notification filed by Branan Medical Corporation with the FDA for Oratect Oral Fluid Drug Screen Devices.

Pre-market Notification Details

Device IDK103227
510k NumberK103227
Device Name:ORATECT ORAL FLUID DRUG SCREEN DEVICES
ClassificationEnzyme Immunoassay, Cocaine And Cocaine Metabolites
Applicant BRANAN MEDICAL CORPORATION 140 TECHNOLOGY DRIVE SUITE 400 Irvine,  CA  92618
ContactHuiying Wang
CorrespondentHuiying Wang
BRANAN MEDICAL CORPORATION 140 TECHNOLOGY DRIVE SUITE 400 Irvine,  CA  92618
Product CodeDIO  
Subsequent Product CodeDIF
Subsequent Product CodeDJC
Subsequent Product CodeDJG
Subsequent Product CodeDKZ
Subsequent Product CodeLCM
Subsequent Product CodeLDJ
CFR Regulation Number862.3250 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2010-11-01
Decision Date2012-04-11
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00817405020201 K103227 000
00817405020003 K103227 000
00816565020854 K103227 000
00816565020847 K103227 000
00816555020222 K103227 000
00816555020215 K103227 000
00816555020208 K103227 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.